Sleep Apnoea/Hypopnoea Syndrome

Crofton and Douglas's Respiratory Diseases: Fifth Edition

Volumn 2, Issue , 2008, Pages 1250-1263

  Douglas, Neil J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Airway; Epidemiology; Hypoventilation; Polysomnography; Sleep apnoea

Indexed keywords

EID: 0345382935     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695999.ch47     Document Type: Chapter

References (120)

1. Kryger MH. Sleep apnoea: from the needles of Dionysius to continuous positive airway pressure. Arch Intern Med 1983; 143:2301.
2. Lavie P. Nothing new under the moon. Historical accounts of sleep apnea syndrome. Arch Intern Med 1986; 144: 2025.
3. Wadd W. Comments on Corpulency and Lineaments of Leaness and Memoirs on Diet and Dietetics. London: John Ebers, 1829.
4. Dickens C. The Posthumous Papers of the Pickwick Club. London: Chapman & Hall, 1837.
5. Jung R, Kuhlo W. Neurophysiological studies of abnormal night's sleep and the Pickwickian syndrome. Prog Brain Res 1965; 18: 140.
6. Gastaut H, Tassinari C, Duron B. Etude polygraphic des manifestations episodiques du syndrome de Pickwick. Rev Neurol 1965; 112: 568.
7. Guilleminault C, Van Der Hoed J, Mitler MM. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement W, eds. Sleep Apnea Syndrome. New York: Alan R Liss, 1978: 1.
8. Gould GA, Whyte KF, Rhind GB et al. The sleep hypopnea syndrome. Am Rev Respir Dis 1988; 137: 895.
9. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230.
10. Bearpark H, Elliott L, Grunstein R et al. Snoring and sleep apnea: a population study in Australian men. Am J Respir Crit Care Med 1995; 151: 1459.
11. Olson LG, King MT, Hensley MJ, Saunders NA. Acommunity study of snoring and sleep disordered breathing: health outcomes. Am J Respir Crit Care Med 1995; 152:717.
12. Jennum P, Sjol A. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30-60. J Sleep Res 1992; 1:240.
13. Phillipson EA. Sleep apnea: a major public health problem. N Engl J Med 1993; 328:1271.
14. Hudgel DW, Hendricks C. Palate and hypopharynx: sites of inspiratory narrowing of the upper airway during sleep. Am Rev Respir Dis 1988; 138: 1542.
15. Chaban R, Cole P, Hoffstein V. Site of upper airway obstruction in patients with idiopathic obstructive sleep apnea. Laryngoscope 1988; 98: 641.
16. Hudgel DW. Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 1986; 61: 1403.
17. Bradley TD, Brown IG, Grossman RF. Pharyngeal size in snorers, non-snorers and patients with obstructive sleep apnea. N Engl J Med 1986; 315: 1327.
18. Shelton KE, Gay SB, Hollowell DE, Woodson H, Suratt PM. Mandible enclosure of upper airway and weight in obstructive sleep apnea. Am Rev Respir Dis 1993; 148:195.
19. Martin SE, Marshall I, Douglas NJ. The effect of posture on airway caliber in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1995; 152: 721.
20. Horner RL, Mohiaddin RH, Lowell DG. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989; 2: 613.
21. Mortimore IL, Marshall I, Wraith PK, Sellar RJ, Douglas NJ. Neck and total body fat deposition in nonobese and obese patients with sleep apnea compared with that in control subjects. Am J Respir Crit Care Med 1998; 157: 280.
22. Douglas NJ. The sleep apnoea/hypopnoea syndrome. Eur J Clin Invest 1995; 25: 285.
23. Partinen M, Guilleminault C, Quera-Salva M, Jamieson A. Obstructive sleep apnea and cephalometric roentgenograms: the role of anatomic upper airway abnormalities in the definition of abnormal breathing during sleep. Chest 1988; 93: 1199.
24. Ferguson KA, Ono T, Lowe AA, Ryan F, Fleetham JA. The relationship between obesity and craniofacial structure in obstructive sleep apnea. Chest 1995; 108: 375.
25. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea/hypopnea syndrome. Ann Intern Med 1995; 122: 174.
26. Issa FG, Sullivan CE. Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 1984; 57: 520.
27. Gleadhill IC, Schwartz AR, Schubert N, Wise RA, Permutt S, Smith PL. Upper airway collapsibility in snorers and in patients with obstructive hypopnea and apnea. Am Rev Respir Dis 1991; 143: 1300.
28. Brown IG, Bradley TD, Phillipson EA, Zamel N, Hoffstein V. Pharyngeal compliance in snoring subjects with and without obstructive sleep apnea. Am Rev Respir Dis 1985; 132: 211.
29. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89: 1571.
30. Douglas NJ, Jan MA, Yildirim N, Warren PM, Drummond GB. Effect of posture and breathing route on genioglossal electromyogram activity in normal subjects and in patients with the sleep apnea/hypopnea syndrome. Am Rev Respir Dis 1993; 148:1341.
31. Mortimore IL, Douglas NJ. Palatal muscle EMG response to negative pressure in awake sleep apneic and control subjects. Am J Respir Crit Care Med 1997; 156: 867.
32. Wheatley JR, Mezzanotte WS, Tangel DJ, White DP. Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 1993; 148:597.
33. Kimoff RJ, Cheong TH, Olha AE et al. Mechanisms of apnea termination in obstructive sleep apnea. Am J Respir Crit Care Med 1994; 149: 707.
34. Guilleminault C, Stoohs R, Duncan S. Snoring: daytime sleepiness in regular heavy snorers. Chest 1991; 99: 40.
35. Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. Acause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest 1993; 104: 781.
36. Douglas NJ, Polo O. Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 653.
37. Cheshire K, Engleman H, Deary I, Douglas N. Factors impairing daytime performance in patients with the sleep apnea/hypopnea syndrome. Arch Intern Med 1992; 152: 538.
38. Martin SE, Engleman HM, Deary IJ, Douglas NJ. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 1996; 153: 1328.
39. Davies RJO, Vardi-Visy K, Clarke M, Stradling JR. Identification of sleep disruption and sleep disordered breathing from the systolic blood pressure profile. Thorax 1993; 48: 1242.
40. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at sevenyear follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27.
41. Whyte KF, Allen MB, Jeffrey AA, Gould GA, Douglas NJ. Clinical features of the sleep apnoea/hypopnoea syndrome. Q J Med 1989; 72: 659.
42. Warley AR, Stradling JR. Abnormal diurnal variation in salt and water excretion in patients with obstructive sleep apnoea. Clin Sci 1988; 74: 183.
43. Bradley T, Rutherford R, Grossman R. Role of daytime hypoxemia in the pathogenesis of right heart failure in obstructive sleep apnea syndrome. Am Rev Respir Dis 1985; 131: 835.
44. Whyte KF, Douglas NJ. Peripheral edema in the sleep apnea/hypopnea syndrome. Sleep 1991; 14: 354.
45. Sandblom RE, Matsumoto AM, Schoene RB. Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 1983; 308: 508.
46. Johnson MW, Anch AM, Remmers JE. Induction of the obstructive sleep apnea syndrome in a women by exogenous androgen administration. Am Rev Respir Dis 1984; 129: 1023.
47. Cistulli PA, Grunstein RR, Sullivan CE. Effect of testosterone administration on upper airway collapsibility during sleep. Am J Respir Crit Care Med 1994; 149: 530.
48. White DP, Lombard RM, Cadieux RJ, Zwillich CW. Pharyngeal resistance in normal humans: influence of age, gender and obesity. J Appl Physiol 1985; 58: 365.
49. Burger CD, Stanson AW, Sheedy PF, Daniels BK, Shepard JW. Fast computed tomography evaluation of age related changes in upper airway structure and function in normal men. Am Rev Respir Dis 1992; 145:846.
50. HEJ, Kryger M, Zorick F, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9.
51. Lavie P, Herer P, Peled R et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18: 149.
52. Young T, Blustein J, Finn L, Palta M. Sleepdisordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20: 608.
53. George C, Nickerson P, Millard T, Kryger M. Sleep apnea patients have more automobile accidents. Lancet 1987; ii: 447.
54. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138: 337.
55. Haraldsson PO, Carenfelt C, Diderichsen F, Nygren A, Tingvall C. Clinical symptoms of sleep apnea syndrome and automobile accidents. ORL J Otorhinolaryngol Relat Spec 1990; 52: 57.
56. Horne JA, Reyner LA. Sleep related vehicle accidents. Br Med J 1995; 310: 565.
57. Zulley J, Cronlein T, Hell W, Langwieder K. Falling asleep at the wheel: the chief cause of severe traffic accidents. Wien Med Wochenschr 1995; 145: 473.
58. George CFP, Boudreau AC, Smiley A. Simulated driving performance in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 154: 175.
59. Engleman HM, Hirst WSJ, Douglas NJ. Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome. J Sleep Res 1997; 6: 272.
60. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994; 120: 382.
61. Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157: 1746.
62. Jennum P, Sjol A. Snoring, sleep apnea, cardiovascular risk factors: the MONICA II study. Int J Epidemiol 1993; 22: 439.
63. Olson LG, King MT, Hensley MJ, Saunders NA. Acommunity study of snoring and sleep-disordered breathing. Am J Respir Crit Care Med 1995; 152: 711.
64. Huang J, Whitford E, Parsons R, Hillman D. Association of sleep apnea with myocardial infarction in men. Lancet 1990; 336: 261.
65. Norton PG, Dunn EV. Snoring as a risk factor for disease: an epidemiological survey. Br Med J 1985; 291: 630.
66. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet 1985; 2: 1325.
67. Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Med J 1987; 294: 16.
68. Spriggs DA, French JM, Murdy JM, Curless RH, Bates D, James OFW. Snoring increases the risk of stroke and adversely affects prognosis. Q J Med 1992; 84: 555.
69. Bradley TD, Rutherford R, Lue F et al. Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 1986; 134: 920.
70. Mathur R, Douglas NJ. Relation between sudden infant death syndrome and adult sleep apnoea/hypopnoea syndrome. Lancet 1994; 344: 819.
71. Tishler PV, Redline S, Ferrette V, Hans MG, Altose MD. The association of sudden unexpected infant death with obstructive sleep apnea. Am J Respir Crit Care Med 1996; 153:1857.
72. Rees K, Wright A, Keeling JW, Douglas NJ. Facial structure in the sudden infant death syndrome: case-control study. Br Med J 1998; 317: 179.
73. Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine, 2nd edn. Philadelphia: WB Saunders, 1994.
74. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test. Sleep 1986; 9: 519.
75. Kump K, Whalen C, Tishler P et al. Assessment of the validity and utility of a sleepsymptom questionnaire. Am J Respir Crit Care Med 1994; 150: 735.
76. Hoffstein V, Szalai J. Predictive value of clinical features in diagnosing obstructive sleep apnea. Sleep 1993; 16: 118.
77. Crocker BD, Olson LG, Saunders NA et al. Estimation of the probability of disturbed breathing during sleep before a sleep study. Am Rev Respir Dis 1990; 142: 14.
78. Maislin G, Pack A, Kribbs N et al. Asurvey screen for prediction of apnea. Sleep 1995; 18:158.
79. Douglas NJ, Thomas S, Jan MA. Clinical value of polysomnography. Lancet 1992; 339:347.
80. Atlas Taskforce of the American Sleep Disorders Association. EEG arousals: scoring, rules and examples. Apreliminary report. Sleep 1992; 15: 174.
81. Davies RJO, Belt PJ, Roberts SJ. Arterial blood pressure responses to graded tran sient arousal from sleep in normal humans. J Appl Physiol 1993; 74: 1123.
82. Pitson D, China N, Knijn S, Herwaaden MV, Stradling J. Changes in pulse transit time and pulse rate as markers of arousal from sleep in normal subjects. Clin Sci 1994; 87:269.
83. Series F, Marc I, Cormier YLA, Forge J. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Ann Intern Med 1993; 119: 449.
84. Issa F, Sullivan C. Reversal of central sleep apnea using nasal CPAP. Chest 1986; 90: 165.
85. Whyte KF, Allen MB, Fitzpatrick MF, Douglas NJ. Accuracy and significance of scoring hypopneas. Sleep 1992; 15: 257.
86. Condos R, Norman R, Krishnasamy I, Peduzzi N, Goldring R, Rapoport D. Flow limitation as a noninvasive assessment of residual upper-airway resistance during continuous positive airway pressure therapy of obstructive sleep apnea. Am J Respir Crit Care Med 1994; 150: 475.
87. Stoohs R, Guilleminault C. MESAM 4: an ambulatory device for the detection of patients at risk for obstructive sleep apnea syndrome (OSAS). Chest 1992; 101: 1221.
88. Issa FG, Morrison D, Hadjuk E, Iyer A, Feroah T, Remmers JE. Digital monitoring of sleep-disordered breathing using snoring sound and arterial oxygen saturation. Am Rev Respir Dis 1993; 148: 1023.
89. Whittle AT, Finch SP, Mortimore IL, MacKay TW, Douglas NJ. Use of home sleep studies for diagnosis of the sleep apnoea/ hypopnoea syndrome. Thorax 1997; 52: 1068.
90. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343: 572.
91. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 1997; 52: 114.
92. Sullivan CE, Berthon-Jones M, Issa FG, Eves L. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1981; i:862.
93. Sanders MH, Kern NB, Costantino JP. Adequacy of prescribing positive airway pressure therapy by mask for sleep apnea on the basis of a partial-night trial. Am Rev Respir Dis 1993; 147: 1169.
94. Engleman HM, Martin SE, Kingshott RN, MacKay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53: 341.
95. Hardinge FM, Bitson DJ, Stradling JR. Use of Epworth sleepiness scale to demonstrate response treatment with nasal continuous positive airway pressure in patients with obstructive sleep apnea. Respir Med 1995; 89:617.
96. Smith IE, Shneerson JM. Is the SF-36 sensitive to sleep disruption? a study in patients with sleep apnoea. J Sleep Res 1995; 4: 183.
97. George CFP, Boudreau AC, Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax 1997; 52: 648.
98. Krieger J, Meslier N, Lebrun T et al. Accidents in obstructive sleep apnea patients treated with nasal continuous positive airway pressure. Chest 1997; 112: 1561.
99. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470.
100. Wright J, Johns R, Watt I et al. Health effects of obstuctive sleep apnoea and effectiveness of continuous positive airway pressure: a systematic review of the research evidence. Br Med J 1997; 314: 851.
101. Douglas NJ. Systematic review of the efficacy of nasal CPAP. Thorax 1998; 53:414.
102. Australian Health Technology Advisory Committee. The effectiveness and cost effectiveness of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea in adults. Canberra: Government Public Services, 1998.
103. Mawhinney H, Spector SL, Kinsman RA et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy 1991; 66: 294.
104. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 1994; 49: 263.
105. Reeves-Hoche MK, Hudgel DW, Meck R, Witteman R, Ross A, Zwillich CW. Continuous versus bilevel positive airway pressure for obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 443.
106. Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18: 501.
107. Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. Randomised crossover study of oral appliances versus nasal continuous positive airway pressure therapy in the treatment of the mild-moderate obstructive sleep apnea. Chest 1996; 109: 1269.
108. O'Sullivan RA, Hillman DR, Mateljan R, Pantin C, Finucane KE. Mandibular advancement splint: an appliance to treat snoring in obstructive sleep apnea. Am J Respir Crit Care Med 1995; 151: 194.
109. Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1981; 89: 923.
110. Gislason T, Lindholm C, Almqvist M. Uvulopalatopharyngoplasty in the sleep apnea syndrome. Predictors of results. Arch Otolaryngol Head Neck Surg 1988; 114: 45.
111. Larsson H, Carlsson-Nordlander B, Svanborg E. Long-time follow-up after UPPP for obstructive sleep apnea syndrome. Acta Otolaryngol 1991; 111: 582.
112. Conway W, Fujita S, Zorick F. Uvulopalatopharyngoplasty. One-year followup. Chest 1985; 88: 385.
113. Mortimore IL, Bradley PA, Murray JAM, Douglas NJ. Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996; 154: 1759.
114. Hudgel DW, Harasick T, Katz RL, Witt WJ, Abelson TI. Uvulopalatopharyngoplasty in obstructive apnea: value of preoperative localization of site of upper airway narrowing during sleep. Am Rev Respir Dis 1991; 143: 942.
115. Shepard JW, Thawley SE. Evaluation of the upper airway by computerized tomography in patients undergoing uvulopalatopharyngoplasty for obstructive sleep apnea. Am Rev Respir Dis 1989; 140: 711.
116. Keenan SP, Burt H, Ryan F, Fleetham JA. Long-term survival of patients with obstructive sleep apnea treated by uvulopalatopharyngoplasty or nasal CPAP. Chest 1994; 105: 155.
117. Riley RW, Powell NB, Guilleminault C. Maxillofacial surgery and nasal CPAP. A comparison of treatment for obstructive sleep apnea syndrome. Chest 1990; 98:1421.
118. Miki H, Hida W, Chonan T, Kikuchi Y, Takishima T. Effects of submental electrical stimulation during sleep on upper airway patency in patients with obstructive sleep apnea. Am Rev Respir Dis 1989; 140:1285.
119. White DP, Zwillich CW, Pickett CK, Douglas NJ, Hudgel DW, Weil JV. Central sleep apnea: improvement with acetazolamide therapy. Arch Intern Med 1982; 142:1816.
120. Working Party of the Royal College of Physicians of London. Sleep Apnoea and Related Conditions. London: Royal College of Physicians, 1993.